Patalinghog, Flora .
HRN: 19-04-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
METRONIDAZOLE 500MG (TAB)
05/30/2025
06/06/2025
PO
500mg
TID
AGE
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: